List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 34 studies with search of: "Medarex" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: Treatment of metastatic melanoma
2 Completed A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: MDX-060
3 Recruiting Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Conditions: Renal Cell Carcinoma;   Non-Hodgkin's Lymphoma
Intervention: Biological: MDX-1203
4 Completed Long-term Data Collection for Subjects in MDX-010 Studies
Condition: Metastatic Melanoma
Intervention:
5 Recruiting Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: MDX-1342
6 Recruiting Study of MDX-1411 Given Every 14 Days With Pre-Medications to Subjects With Clear Cell Kidney Cancer.
Condition: Kidney Cancer
Intervention: Biological: MDX 1411
7 Active, not recruiting A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Colorectal Cancer;   Malignant Melanoma;   Renal Cancer;   Prostate Cancer
Intervention: Biological: MDX-1106
8 Recruiting A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC);   Renal Cell Carcinoma (RCC);   Malignant Melanoma (MEL);   Non-small Cell Lung Cancer (NSCLC)
Intervention: Biological: MDX-1106
9 Recruiting Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: MDX-1342
10 Completed Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Biological: MDX-010
11 Recruiting Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma
Condition: Hodgkin's Lymphomas
Intervention: Biological: MDX-1401
12 Withdrawn Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma
Condition: Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma.
Intervention: Biological: MDX-1411
13 Completed MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Melanoma
Conditions: Melanoma;   Metastases
Interventions: Drug: MDX-010 (anti-CTLA4) monoclonal antibody;   Biological: MDX-1379 Melanoma Peptide Vaccine
14 Recruiting Study of MDX-1105 in Subjects With Selected Advanced or Recurrent Solid Tumors
Conditions: Renal Cell Carcinoma;   Non-small Cell Lung Cancer;   Malignant Melanoma;   Epithelial Ovarian Cancer;   Colorectal Adenocarcinoma
Intervention: Biological: MDX-1105
15 Withdrawn MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
Condition: Lymphoma, Large-Cell
Intervention: Drug: MDX-060
16 Completed Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: MDX-1100;   Drug: Placebo
17 Completed A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
Condition: Hepatitis C
Interventions: Drug: MDX1106-02;   Drug: Placebo
18 Completed Study of MDX-010 in Stage IV Breast Cancer
Conditions: Breast Cancer;   Adenocarcinoma
Intervention: Drug: MDX-010
19 Completed A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: MDX-1100 (anti-CXCL10 human monoclonal antibody)
20 Completed Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer
Conditions: Prostate Cancer;   Neoplasm Metastasis
Intervention: Drug: MDX-010

Previous Page Studies Shown (1-20) Next Page (21-34)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services